STAT Plus: What we learned about the business of telemedicine from Amwell and GoodRx’s IPO filings
Last week, two virtual care providers filed paperwork to go public — offering an unprecedented window into the long-murky finances of telemedicine.
The illuminating S-1 regulatory filings came from Boston-based telehealth provider Amwell and GoodRx, the Los Angeles-based prescription drug coupons company that last year acquired the telemedicine company HeyDoctor.
